Self-Organization
Cell interactions and developmental programs can produce organized multicellular structures.
Explore how stem cells generate organized three-dimensional structures, how organoids reproduce selected features of human tissues, and why advanced cell models are transforming developmental biology and biomedical research.
Organoids are three-dimensional cellular structures that arise from stem or progenitor cells and reproduce selected organizational and functional characteristics of particular tissues or organs.
The development of organoid technology builds upon the ability of certain cells to organize themselves in response to biological signals and their surrounding environment. Under suitable culture conditions, stem cells can establish spatially organized populations containing differentiated descendants.
Organoids are not miniature complete organs. Their complexity, maturity and physiological resemblance vary considerably depending on the model and experimental conditions. They nevertheless offer ways to investigate human tissue biology that conventional monolayer cultures may not reproduce.
Cell interactions and developmental programs can produce organized multicellular structures.
Some organoids contain multiple specialized cell populations representing parts of a tissue.
Three-dimensional organization influences interactions, polarity and local signaling environments.
Depending on the model, organoids can reproduce selected physiological features of native tissues.
Organoid formation involves interconnected cellular processes including proliferation, differentiation, adhesion, mechanical interactions and tissue patterning.
Morphogen signaling pathways, cell polarity, extracellular matrix interactions and cell-to-cell communication contribute to the spatial organization of developing structures. These mechanisms vary between organoid systems.
Stem cells or tissue-derived progenitors provide the cellular foundation.
Adhesion and communication influence initial three-dimensional organization.
Cell fate decisions and local signals establish spatial differences.
Emerging tissue-like features are assessed through biological assays.
Not every three-dimensional cellular aggregate qualifies as an organoid. The terminology should reflect demonstrated cell identity, organization and relevant functional properties.
Organoid systems differ according to the origin and developmental potential of their starting cell populations.
| Characteristic | Adult Stem Cell-Derived | Pluripotent Stem Cell-Derived |
|---|---|---|
| Starting material | Tissue-resident stem or progenitor cells. | Embryonic stem cells or iPSCs. |
| Developmental scope | Typically reflects a more restricted tissue lineage. | Can model aspects of earlier developmental specification. |
| Common research use | Adult epithelial biology, tissue maintenance and disease. | Development, tissue specification and genetic disease models. |
| Cellular composition | Depends on tissue source and culture conditions. | Depends on directed differentiation and self-organization. |
| Limitations | May lack non-epithelial and systemic tissue components. | May exhibit immature or heterogeneous cell populations. |
Neither approach is universally superior. The appropriate model depends on the biological question, cell source, developmental stage and properties that must be reproduced.
Organoid systems have been developed for numerous tissue types, allowing researchers to investigate selected aspects of human development and disease.
Models of selected aspects of brain development, neural organization and neurological disease-associated phenotypes.
Models of intestinal epithelial cell differentiation, renewal, barrier biology and selected gastrointestinal disorders.
Used to investigate nephron-related developmental processes, kidney disease mechanisms and certain toxicological responses.
Enable investigation of selected hepatic and biliary cellular functions, development and disease mechanisms.
Reproduce selected developmental features of retinal tissue and support models of inherited retinal disorders.
Patient-derived cancer organoids can support studies of tumor biology, heterogeneity and experimental drug responses.
The extracellular environment influences organoid architecture, cellular polarity, survival and differentiation.
Some organoid systems use extracellular matrix-rich hydrogels, whereas others rely on alternative scaffolds, suspension culture or engineered supports. Matrix properties influence the physical and biochemical conditions experienced by cells.
Matrices containing biological extracellular components provide adhesion-related and mechanical cues, but composition and lot variability can be important.
Engineered materials offer opportunities to control selected mechanical and biochemical properties in a more defined experimental environment.
Some self-organizing systems can be maintained as aggregates under suspension conditions, depending on the biological model.
Dynamic culture systems can modify mixing and transport conditions, although suitability depends on organoid characteristics.
Matrix formulation, culture medium, oxygen availability, organoid size and cell source can all affect model variability and interpretation.
Different culture technologies reproduce different aspects of biological complexity. Model choice should reflect the research question rather than three-dimensional structure alone.
| System | Principal Characteristics | Typical Applications |
|---|---|---|
| 2D Monolayer | Cells grown on a predominantly flat surface. | Cellular assays, imaging and many screening workflows. |
| Spheroid | Three-dimensional cellular aggregate, often with relatively limited tissue-specific organization. | Tumor microenvironments, cell interactions and compound response. |
| Organoid | Self-organizing model reproducing selected tissue-specific structures or properties. | Development, disease modeling and tissue-specific functional studies. |
| Organ-on-Chip | Engineered microphysiological model that may incorporate flow, mechanical cues and tissue interfaces. | Barrier function, dynamic physiological processes and compound assessment. |
Hybrid approaches can also combine organoids with microfluidic systems or engineered cellular environments, providing additional experimental control.
Organoid research connects stem cell biology with tissue-level questions in medicine, disease biology and experimental therapeutics.
Study selected developmental processes and mechanisms that shape cellular organization.
Investigate the effects of genetic variants within experimentally accessible tissue-like models.
Assess experimental responses to compounds in relevant cellular and tissue contexts.
Examine tumor-associated biology and variation between patient-derived models.
Explore selected tissue-specific interactions with infectious agents under appropriate research containment.
Investigate cellular repair, tissue formation and the behavior of stem cell-derived populations.
Organoid systems offer valuable human experimental models, but their predictive power must be validated for the specific application. Findings should not automatically be extrapolated to intact human organs or clinical outcomes.
Reproducible organoid research requires explicit documentation of starting materials, cellular composition, structural properties and biological function.
Document cell or tissue origin, relevant genetic characteristics and identity verification.
Evaluate lineage markers, population diversity and the presence of unwanted cell states.
Examine relevant tissue architecture, polarity and spatial cellular relationships.
Assess biological properties appropriate to the tissue and intended application.
Compare independent preparations, culture batches and appropriate biological replicates.
Compare molecular and functional properties with relevant native tissue or validated references.
The International Society for Stem Cell Research recommends characterization and reproducibility criteria for stem cell-derived model systems. These include documenting the starting material and validating functional and phenotypic tissue resemblance.
Despite rapid advances, organoid technologies still face limitations in maturity, reproducibility, physiological integration and scale.
Many organoids lack the functional vascular networks of native organs, limiting transport and tissue complexity.
Stem cell-derived organoids can retain developmental features that differ from those of adult tissues.
Important immune and stromal components may be absent unless specifically incorporated.
Variation between donors, cell lines and laboratories complicates comparison across experiments.
Engineered dynamic environments can support studies of perfusion, transport and tissue interfaces.
Co-culture and engineered assembly approaches can introduce additional interacting cell populations.
These approaches may improve the biological relevance of selected models, but each added component also increases the need for characterization and control.
Connect organoid biology with pluripotent stem cell technologies, differentiation science and the materials used in 3D research.
Explore cell identity, self-renewal and developmental potential.
Explore biology →Understand cellular reprogramming and pluripotent models.
Explore iPSCs →Learn about lineage specification, markers and maturation.
Explore differentiation →The content is intended for scientific education and research information. Organoid model characteristics must be evaluated for each particular biological application. No clinical suitability or therapeutic effectiveness is implied.